Table 3.
Top 500 arsenic-associated CpGsa | Arsenic-associated CpGs below b | ||||
---|---|---|---|---|---|
n | Genes | p | Genes | p | |
HEALS | |||||
Angiogenesis | 36 | 3 | — | — | |
Cholesterol homeostasis | 74 | 4 | — | — | |
signaling via | 200 | 7 | — | — | |
META-ANALYSIS | |||||
Allograft rejection | 200 | 9 | 4 | ||
105 | 6 | 3 | |||
Reactive oxygen species pathway | 49 | 3 | 2 | ||
Inflammatory response | 200 | 6 | 3 | ||
signaling via | 200 | 7 | 4 | ||
Estrogen response early | 200 | 10 | — | — | |
UV response up-regulated | 158 | 7 | — | — | |
MTORC1 signaling | 200 | — | — | 4 | |
Oxidative phosphorylation | 200 | — | — | 3 | |
MYC targets V1 | 200 | — | — | 3 | |
Apical junction | 200 | — | — | 4 |
Note: Gene annotations for arsenic-associated CpGs are provided as gene set input for the gometh function. Results are presented for hallmark gene sets ( sets) with at least two genes from arsenic-associated CpG gene set and enrichment (). Background gene set for is 19,246 genes, and EPIC is 23,234 genes. The table reports total number of genes in set (n), genes identified in pathway from CpG gene set, and p-value from CpG bias-corrected hypergeometric test. —, no data; BEST, Bangladesh Vitamin E and Selenium Trial; FDR, false discovery rate; HEALS, Health Effects of Arsenic Longitudinal Study; , tumor necrosis factor .
Top 500 arsenic-associated CpGs, annotated to 348 unique genes in the HEALS discovery analysis (EPIC array), 338 unique genes in the meta-analysis ( array).
Arsenic-associated CpGs (), annotated to 21 unique genes in the discovery analysis, 153 unique genes in the meta-analysis.